Mercor
Biotech Investment Analyst — Drug Asset & Company Assessment
Assess commercial drugs and development programs for a biotech and pharma research team’s AI evaluation work. You’ll build and critique rubrics, review investment theses, and evaluate roughly 5–10 companies during a remote pilot lasting about 10–20 hours over one to two weeks. Strong contributions may lead to recurring work as the project grows.
- Location and eligibility
- Remote · United States only
- Engagement type
- Part-time
- Compensation
- $120–$200/hr
- biotechnology
- pharmaceuticals
- biotech investing

